Comment
Simvastatin reduced mortality and vascular events in diabetes mellitus
Affiliations
- PMID: 14711272
Item in Clipboard
Comment
Simvastatin reduced mortality and vascular events in diabetes mellitus
ACP J Club.
2004 Jan-Feb.
No abstract available
Comment on
-
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.Lancet. 2003 Jun 14;361(9374):2005-16. doi: 10.1016/s0140-6736(03)13636-7. Lancet. 2003. PMID: 12814710 Clinical Trial.
Similar articles
-
Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.Diabetes Res Clin Pract. 2005 Nov;70(2):110-8. doi: 10.1016/j.diabres.2005.03.025. Diabetes Res Clin Pract. 2005. PMID: 16188573 Clinical Trial.
-
Simvastatin was cost-effective for reducing major vascular events in vascular disease or diabetes mellitus.ACP J Club. 2005 Nov-Dec;143(3):80. ACP J Club. 2005. PMID: 16262237 No abstract available.
-
Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats.Diabetes Nutr Metab. 2004 Aug;17(4):203-10. Diabetes Nutr Metab. 2004. PMID: 15575340
-
Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus.Am J Cardiol. 2006 Dec 15;98(12):1656-9. doi: 10.1016/j.amjcard.2006.07.047. Epub 2006 Oct 25. Am J Cardiol. 2006. PMID: 17145229 Clinical Trial.
-
Learning from large cardiovascular clinical trials: classical cardiovascular risk factors.Diabetes Res Clin Pract. 2005 Jun;68 Suppl1:S43-7. doi: 10.1016/j.diabres.2005.03.005. Epub 2005 Apr 8. Diabetes Res Clin Pract. 2005. PMID: 15955374 Review.